Paul Jeffrey Dollings

This inventor holds 20 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: American Home Products Corporation, Wyeth. Active years: 1990-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul Jeffrey Dollings. Retrieved from https://idiyas.com/inventor/paul-jeffrey-dollings

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20

% Patents Active = 65.0

Average Co-Inventor Count = 2.0

ph-index = 5

Forward Citations = 70(Granted Patents)

Company Filing History:

14 out of 1,567

American Home Products Corporation

Years Active: 1990-2009

Loading Chart...

Areas of Expertise:

Acylated Benzylmaltosides

Smooth Muscle Cell Proliferation

Insulin Resistance

Furans

Benzofurans

Thiophenes

Biphenyl Sulfonyl Aryl Carboxylic Acids

Benzylmaltotriosides

Benzopyran Derivatives

Cyclobut-3-ene-1,2-dione

Pyrimidocycloalkanes

Benzopenones

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7514411 - Acylated benzylmaltosides as inhibitors of smooth muscle cell proliferation (2009-04-07),

2. 7256198 - Pyrimidoindolones and methods for using same (2007-08-14),

3. 7132402 - Acylated benzylmaltosides as inhibitors of smooth muscle cell proliferation (2006-11-07),

4. 6683107 - Furans, benzofurans, and thiophenes useful in the treatment of insulin resistance and hyperglycemia (2004-01-27),

5. 6451845 - Furans, benzofurans, and thiophenes useful in the treatment of insulin resistance and hyperglycemia (2002-09-17),

6. 6451767 - Benzylmaltotriosides as inhibitors of smooth muscle cell proliferation (2002-09-17),

7. 6340670 - Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation (2002-01-22),

8. 6310081 - Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia (2001-10-30),

9. 6291434 - Benzylmaltotriosides as inhibitors of smooth muscle cell proliferation (2001-09-18),

10. 6258784 - Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation (2001-07-10),

11. 6248764 - Furans, benzofurans, and thiophenes useful in the treatment of insulin resistance and hyperglycemia (2001-06-19),

12. 6221902 - Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia (2001-04-24),

13. 6187755 - Benzylmaltosides as inhibitors of smooth muscle cell proliferation (2001-02-13),

14. 6121271 - Naphtho[2,3-B]heteroar-4-yl derivatives (2000-09-19),

15. 6103708 - Furans, benzofurans, and thiophenes useful in the treatment of insulin (2000-08-15),

Title: The Inventor Paul Jeffrey Dollings

Introduction: Paul Jeffrey Dollings, a distinguished inventor hailing from Newtown, PA, has made significant contributions to the field of innovation with his groundbreaking ideas and inventions.

Latest Patents: Paul Jeffrey Dollings holds several patents in various industries, including technology, healthcare, and consumer goods. His most recent patent focuses on a revolutionary medical device aimed at improving patient outcomes in surgical procedures.

Career Highlights: With a career spanning over two decades, Paul Jeffrey Dollings has established himself as a visionary inventor known for his ability to transform ideas into tangible products. His innovative approach has led to the successful commercialization of several inventions, earning him recognition in the industry.

Collaborations: Throughout his career, Paul Jeffrey Dollings has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His partnerships have been instrumental in pushing the boundaries of innovation and driving positive change in various sectors.

Conclusion: Paul Jeffrey Dollings' passion for innovation and relentless pursuit of excellence have solidified his reputation as a trailblazing inventor. His dedication to creating solutions that address real-world challenges continues to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]